Clinical Trial Results

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

PHASE1, PHASE2INTERVENTIONAL San Francisco, California +4 more

RECRUITING

A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus

PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

PHASE1, PHASE2INTERVENTIONAL Washington D.C., District of Columbia +2 more

RECRUITING

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

PHASE1, PHASE2INTERVENTIONAL La Palma, California +4 more

RECRUITING

2-HOBA in Systemic Lupus Erythematosus

PHASE2INTERVENTIONAL Nashville, Tennessee

RECRUITING

Dapagliflozin in Active Lupus Nephritis

PHASE4INTERVENTIONAL Boston, Massachusetts +1 more

RECRUITING

Safety of the Herpes Zoster Subunit Vaccine in Lupus

PHASE4INTERVENTIONAL New York, New York +1 more

RECRUITING

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

PHASE4INTERVENTIONAL Farmington, Connecticut +3 more

RECRUITING

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

PHASE4INTERVENTIONAL La Mesa, California +4 more

RECRUITING

Trial of Belimumab in Early Lupus

PHASE4INTERVENTIONAL Manhasset, New York

RECRUITING

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

PHASE4INTERVENTIONAL Glendale, Arizona +4 more

RECRUITING

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

PHASE1INTERVENTIONAL San Francisco, California +4 more

RECRUITING

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

PHASE1INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

PHASE1INTERVENTIONAL Anniston, Alabama +4 more

RECRUITING

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

PHASE1INTERVENTIONAL Apple Valley, California +4 more

RECRUITING

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Alnuctamab for Refractory SLE (LATTE Study)

PHASE1INTERVENTIONAL New York, New York

RECRUITING

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

PHASE1INTERVENTIONAL Allen, Texas +4 more

RECRUITING

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus

PHASE1INTERVENTIONAL Columbus, Ohio

RECRUITING

Effect of Anti-inflammatory Diet in Systemic Lupus Erythematous

NAINTERVENTIONAL La Jolla, California

RECRUITING

Lupus Nephritis Care Pathway

NAINTERVENTIONAL Durham, North Carolina

RECRUITING

HEALTH Home Urinalysis Testing

NAINTERVENTIONAL New York, New York

RECRUITING

Intervention to Improve Communication and Medication Adherence in Lupus

NAINTERVENTIONAL Durham, North Carolina

RECRUITING

Wellness & Workforce Solution for Lupus/Lupus Nephritis

NAINTERVENTIONAL Atlanta, Georgia

RECRUITING